BioXcel Therapeutics Inc (FRA:BX2)
€ 1.892 0.006 (0.32%) Market Cap: 72.49 Mil Enterprise Value: 98.09 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 21/100

BioXcel Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 11, 2021 / 01:00PM GMT
Release Date Price: €30.55 (-0.33%)
Operator

Good morning, and welcome to BioXcel Therapeutics, Inc. 2021 Annual Meeting of Stockholders. I would now like to introduce the first presenter, Chairman of the Board of Directors, Peter Mueller.

Peter R. Mueller
BioXcel Therapeutics, Inc. - Independent Chairman

Good morning everybody. My name is Peter Mueller, the Chairman of the Board of Directors of BioXcel Therapeutics and the Chairperson of today's meeting. I'm very happy to welcome you to our 2021 Annual Meeting of Stockholders. On behalf of BioXcel Therapeutics, the members of the Board and company's management, I hope everyone is safe and healthy.

Before I call the meeting to order, I'd like to introduce to you the other members of the Board of Directors who are with us today. The other members of the Board joining us today are: Dr. Vimal Mehta, our President and Chief Executive Officer; Dr. Krishnan Nandabalan; June Bray; Dr. Sandeep Laumas; and Dr. Michal Votruba.

In addition, participating today are Richard Steinhart, our Chief Financial Officer; and Javier Rodriguez, our Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot